ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 65 filers reported holding ARCUS BIOSCIENCES INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $222 | -66.2% | 12,184 | -61.7% | 0.00% | -62.5% |
| Q4 2022 | $657 | -99.9% | 31,789 | -15.4% | 0.01% | -20.0% |
| Q2 2022 | $952,000 | -68.0% | 37,557 | -60.1% | 0.01% | -54.5% |
| Q1 2022 | $2,973,000 | +183.7% | 94,186 | +263.8% | 0.02% | +266.7% |
| Q4 2021 | $1,048,000 | +10.9% | 25,889 | -4.4% | 0.01% | +50.0% |
| Q3 2021 | $945,000 | +367.8% | 27,090 | +276.2% | 0.00% | +300.0% |
| Q1 2021 | $202,000 | -34.4% | 7,201 | -39.3% | 0.00% | -50.0% |
| Q4 2020 | $308,000 | -44.7% | 11,869 | -63.5% | 0.00% | -50.0% |
| Q3 2020 | $557,000 | +53.4% | 32,526 | +121.8% | 0.00% | +33.3% |
| Q2 2020 | $363,000 | +124.1% | 14,663 | +25.3% | 0.00% | +50.0% |
| Q1 2020 | $162,000 | +47.3% | 11,698 | +33.2% | 0.00% | +100.0% |
| Q1 2019 | $110,000 | – | 8,782 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |